CCAP Stock Recent News

Business Development Companies like Crescent Capital provide an opportunity to collect high distributions in the current high-interest rate environment. CCAP has a diverse portfolio of 186 companies across different industries, mitigating concentration risk. The credit quality remains solid, but non-accruals sit at 2%. Net investment income has consistently grown over the last several quarters, and plenty of supplemental distributions have been declared as a result.

LOS ANGELES, April 18, 2024 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the first quarter ended March 31, 2024 on Wednesday, May 8, 2024 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, May 9, 2024 at 12:00 p.m.

Crescent Capital BDC has shown strong earnings growth, with net investment income and total investment income increasing quarter-over-quarter. The company has also demonstrated healthy NAV growth, out-earning its dividend and seeing a 1.7% increase in NAV quarter-over-quarter. Despite its performance, Crescent Capital still trades at a 15% discount to NAV, presenting a buying opportunity for income investors.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Crescent Capital BDC (CCAP) closed at $17.50 in the latest trading session, marking a +0.81% move from the prior day.

Crescent Capital BDC (CCAP) closed at $16.99 in the latest trading session, marking a -1.51% move from the prior day.

Crescent Capital is a top BDC with the potential for solid long-term returns and downside protection through diversified debt investments. The company's outlook for 2024 is promising due to growth trends in the leveraged buyout market and improving end markets. CCAP is well-positioned to benefit from increased LBO activity with strong relationships with private equity sponsors and solid liquidity.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

In the closing of the recent trading day, Crescent Capital BDC (CCAP) stood at $16.27, denoting a +0.93% change from the preceding trading day.

The latest trading day saw Crescent Capital BDC (CCAP) settling at $16.12, representing a -0.31% change from its previous close.